Neogenomics Inc
NEO· Nasdaq
NEONeogenomics Inc
Filed Oct 30, 2013 · 10-Q · 30 days after period end · 0001193125-13-417340
| Metric | Q3 2013 | Q3 2012 | Q3 2011 | Q3 2010 |
|---|---|---|---|---|
| Net Income | $900.00K | -$975.00K | -$143.00K | -$1.20M |
| EPS Diluted | $0.02 | -$0.02 | $0.00 | -$0.03 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Neogenomics Inc · CIK 1077183 · Engraved from SEC EDGAR
ended Sep 30, 2013 · filed Oct 30, 2013 · 30 d after period end
